Hexarelin

$70.00

  • Contents: Hexarelin
  • Form: Lyophilized powder
  • Purity: >99%
Quantity Discount Price
4 - 7 10% $63.00
8 + 18% $57.40
SKU: N/A Category:

Description

Hexarelin is a synthetic hexapeptide studied in controlled laboratory environments for its potent agonist activity at the growth hormone secretagogue receptor (GHSR-1a), making it a frequently selected tool in research models focused on GH signaling pathways and related downstream effects.

Key Characteristics

  • Synthetic hexapeptide and potent GHSR-1a agonist
  • Among the more efficacious GH secretagogue receptor ligands studied in preclinical models
  • Investigated alongside compounds such as Ipamorelin and Sermorelin for comparative receptor binding and selectivity studies
  • Compact six-amino-acid structure associated with relatively high receptor binding affinity
  • Commonly selected in GH axis research, where strong receptor activation is a key experimental variable

Handling and Storage

Maintaining stable storage conditions is an important part of working with short-chain peptides such as Hexarelin. The compound should be kept away from heat, moisture, and light to preserve structural integrity. Consistent handling practices from receipt through the end of the research period help ensure reliable analytical outcomes.

FAQs

What is Hexarelin?
Hexarelin is a synthetic hexapeptide studied in laboratory environments for its high-affinity agonist activity at the GHSR-1a receptor, with applications in GH axis signaling research and comparative secretagogue studies.

How does Hexarelin compare to Ipamorelin?
Both Hexarelin and Ipamorelin are GHSR-1a agonists, but Hexarelin is generally observed to have higher receptor binding potency in cell-based models. Ipamorelin is more commonly noted for its selectivity, making the two compounds useful for different experimental objectives within the same receptor system.

Is Hexarelin selective for GHSR-1a or does it interact with other receptors?
Unlike some other GH secretagogues, Hexarelin has been observed to interact with receptors beyond GHSR-1a in preclinical models, including CD36 scavenger receptors. This makes it a useful compound in studies where broader receptor interaction profiles are part of the research question.